First Personal Financial Services Aerie Pharmaceuticals Inc Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$47.85 - $70.45 $15,455 - $22,755	-323 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$51.15 - $61.0 $11,253 - $13,420	-220 Reduced 40.52%	323 $18,000
Q4 2017 Jan 25, 2018	BUY	$50.85 - $65.1 $406 - $520	8 Added 1.5%	543 $32,000
Q3 2017 Nov 01, 2017	BUY	$48.6 - $60.1 $26,001 - $32,153	535	535 $26,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.